The struggle to bring Addyi to the market exposes persistent gender bias in medicine, particularly in how women’s sexual ...
Sex, Drugs & Who Has Control” — premiering Friday on Paramount+ — explores the obstacles that Addyi overcame to securing FDA ...
In exclusive interviews, the filmmakers behind 'The Pink Pill' documentary share how they brought the fight for FDA approval ...
Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...
A documentary praising a pharma company and its founder? This rare breed, titled “The Pink Pill,” is now streaming on ...
A new documentary, 'The Pink Pill: Sex, Drugs and Who Has Control,' explores the fight to bring the women’s sexual health pill, Addyi, to market Addyi; Catalyst Works The new documentary, The Pink ...
RALEIGH, N.C., Jan. 29, 2026 /PRNewswire/ -- Sprout Pharmaceuticals today announced that Addyi® has been named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards, one of the ...
Sex, Drugs & Who Has Control on Paramount+ chronicles the political, scientific and cultural battle to get Addyi, the first treatment of hypoactive sexual desire disorder (HSDD) ...
The FDA has approved a pill to boost a woman’s sexual desire. Dubbed, “the female Viagra," this medication works a little differently than the little blue pill. It affects a woman’s brain, where ...
In documentary The Pink Pill, the fight to provide access to the so-called ‘female Viagra’ exposes an industry that still discounts the needs of women ...
The MarketWatch News Department was not involved in the creation of this content. Recognition follows Addyi's newly expanded FDA approval to treat both premenopausal and postmenopausal women under age ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results